As of May 22
| +0.75 / +1.65%|
The 12 analysts offering 12-month price forecasts for Impax Laboratories Inc have a median target of 45.50, with a high estimate of 58.00 and a low estimate of 27.00. The median estimate represents a -1.54% decrease from the last price of 46.21.
The current consensus among 13 polled investment analysts is to Hold stock in Impax Laboratories Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.